Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Vaxart Inc (VXRT)

Vaxart Inc (VXRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Vaxart Inc 170 Harbor Way Suite 300 South San Francisco CA 94080 USA

www.vaxart.com Employees: 109 P: 650-550-3500 F: 650-871-8580

Description:

Vaxart, Inc. is a clinical-stage company developing a range of oral recombinant vaccines based on its proprietary delivery platform. The company's vaccines are administered using convenient room temperature-stable tablets that can be stored and shipped without refrigeration and eliminate risk of needle-stick injury. Its development programs are oral tablet vaccines designed to protect against norovirus, seasonal influenza and respiratory syncytial virus, as well as a therapeutic vaccine for human papillomavirus. Vaxart, Inc., formerly known as Aviragen Therapeutics, is based in South San Francisco, United States.

Key Statistics

Overview:

Market Capitalization, $K 136,488
Enterprise Value, $K 101,728
Shares Outstanding, K 227,480
Annual Sales, $ 7,380 K
Annual Net Income, $ -82,470 K
Last Quarter Sales, $ 4,930 K
Last Quarter Net Income, $ -14,080 K
EBIT, $ -71,710 K
EBITDA, $ -63,740 K
60-Month Beta 0.70
% of Insider Shareholders 2.60%
% of Institutional Shareholders 18.05%
Float, K 221,566
% Float 97.40%
Short Volume Ratio 0.51

Growth:

1-Year Return -16.78%
3-Year Return -91.98%
5-Year Return 84.62%
5-Year Revenue Growth 77.40%
5-Year Earnings Growth 78.49%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.06 on 11/13/24
Next Earnings Date N/A
Earnings Per Share ttm -0.41
EPS Growth vs. Prev Qtr 33.33%
EPS Growth vs. Prev Year 45.45%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-11 on 02/14/18

VXRT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -110.46%
Return-on-Assets % -62.78%
Profit Margin % -1,117.48%
Debt/Equity 0.00
Price/Sales 18.48
Price/Cash Flow N/A
Price/Book 1.99
Book Value/Share 0.39
Interest Coverage -55.69
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar